Royal College of Physicians (RCP) standards (n=163 patients followed up for ≥12 months)
Quality standard: the patient record shows that | Total number of patients with available data | Total number of patients meeting quality standard | Quality standard achieved for patients with available data (%) | Quality standard met for all patients (%)* | |
1a | Blood pressure (BP) has been documented in the last 12 months | 163 | 147 | 90.2 | NA |
1b | Most recent BP ≤130/80 mm Hg | 147 | 57 | 38.8 | 35.0 |
2a | Total cholesterol has been documented in the last 12 months | 163 | 110 | 67.5 | NA |
2b | LDL has been documented in the last 12 months | 163 | 90 | 55.2 | NA |
2c | Total cholesterol and LDL have been documented in the last 12 months | 163 | 90 | 55.2 | NA |
2d | Most recent total cholesterol <4 mmol/l | 110 | 45 | 40.9 | 27.6 |
2e | Most recent total cholesterol <4.0 mmol/l or 25% reduction in total cholesterol, whichever achieves the lowest absolute value | 106 | 17 | 16.0 | 10.4 |
2f | Most recent LDL <2 mmol/l | 90 | 37 | 41.1 | 22.7 |
2g | Most recent total cholesterol <4.0 mmol/l and most recent LDL <2.0 mmol/l | 90 | 26 | 28.9 | 16.0 |
3a | Antihypertensives are prescribed if BP >130/80: ACE inhibitor or ARB or CCB or thiazide-type diuretic | 90 | 64 | 71.1 | 67.0 |
Calcium channel CCB | 64 | 29 | 45.3 | NA | |
Thiazide diuretic | 64 | 17 | 26.7 | NA | |
ACE inhibitor | 64 | 32 | 50.0 | NA | |
ARB | 64 | 15 | 25.0 | NA | |
1 Class of antihypertensive | 64 | 39 | 60.9 | NA | |
2 Classes of antihypertensive | 64 | 21 | 32.8 | NA | |
3 Classes of antihypertensive | 64 | 4 | 6.3 | NA | |
3b | Antithrombotics are prescribed: aspirin and dipyridamole, aspirin alone, clopidogrel or anticoagulation | 163 | 151 | 92.6 | NA |
Aspirin and dipyridamole | 163 | 57 | 35.0 | NA | |
Aspirin alone | 163 | 60 | 36.8 | NA | |
Clopidogrel alone | 163 | 15 | 9.2 | NA | |
Other antiplatelet(s) | 163 | 8 | 4.9 | NA | |
Anticoagulant | 163 | 14 | 8.6 | NA | |
No antithrombotics prescribed | 163 | 9 | 5.5 | NA | |
3c | Statins are prescribed if total cholesterol >3.5 mmol/l or LDL >2.5 mmol/l (ie, both measured) | 72 | 58 | 81.0 | 77.9 |
4a | Documented in the last 12 months | ||||
Smoking status | 163 | 140 | 85.9 | NA | |
Dietary advice | 163 | 48 | 29.4 | NA | |
Exercise advice | 163 | 55 | 33.7 | NA | |
BMI | 163 | 72 | 44.2 | NA | |
Smokers have been given cessation advice | 19 | 17 | 89.5 | NA | |
Overweight (BMI≥25) and obese (BMI≥30) patients have been given weight loss advice (dietary or exercise advice) | 58 | 27 | 46.6 | NA | |
5a |
| 87 | 12 | 13.8 | 7.4 |
5b | Combined secondary prevention medication: prescribed an antihypertensive, a statin and an antithrombotic | 163 | 90 | 55.2 | NA |
↵* Assuming that patients with unavailable data did not meet the quality standard.
ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blocker; BMI, body mass index; CCB, calcium channel blocker; LDL, low-density lipoprotein; NA, not applicable.